Qingdao Baheal Medical INC. (SHE:301015)
China · Delayed Price · Currency is CNY 23.98
+0.05 (0.21%)
At close: Feb 6, 2026
SHE:301015 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 527.03 | 691.59 | 712.06 | 502.09 | 421.64 | 272.71 |
Depreciation & Amortization | 74.48 | 74.48 | 86.14 | 54.86 | 41.18 | 19.59 |
Other Amortization | 17.73 | 17.73 | 5.27 | 6.67 | 12.01 | 3.21 |
Loss (Gain) From Sale of Assets | -0.93 | -0.93 | 6.57 | -0.57 | -0.1 | -0.48 |
Asset Writedown & Restructuring Costs | 0.46 | 0.46 | 0.35 | 0.04 | 0.01 | 0.14 |
Loss (Gain) From Sale of Investments | -56.85 | -56.85 | -48.5 | 8.87 | -9.77 | -8.84 |
Provision & Write-off of Bad Debts | 11.26 | 11.26 | 32.87 | 13.08 | -1.53 | 10.03 |
Other Operating Activities | 387.21 | 163.65 | 128.92 | 36.81 | 56.33 | 78.78 |
Change in Accounts Receivable | -85.14 | -85.14 | -104.15 | -386.9 | -373.68 | -542.58 |
Change in Inventory | -70.23 | -70.23 | -57.96 | -70.37 | -10.89 | -128.43 |
Change in Accounts Payable | 64.5 | 64.5 | 49.02 | 148.45 | 39.62 | 175.54 |
Change in Other Net Operating Assets | - | - | - | - | 0.2 | 2.33 |
Operating Cash Flow | 872.84 | 813.85 | 799.5 | 305.75 | 181.3 | -116.83 |
Operating Cash Flow Growth | -4.26% | 1.80% | 161.48% | 68.65% | - | - |
Capital Expenditures | -304.55 | -303.99 | -185.49 | -105.32 | -27.49 | -16.35 |
Sale of Property, Plant & Equipment | 0.08 | 0.79 | 6.09 | 0.91 | 0.13 | 0.35 |
Cash Acquisitions | -3.39 | -3.39 | - | -5.76 | - | 0.74 |
Divestitures | 4.43 | 4.43 | 16.35 | 7.78 | 6.11 | - |
Investment in Securities | -456.02 | -437.83 | -137.39 | -18.24 | -4.48 | -30.84 |
Other Investing Activities | 8 | 7.68 | 4.73 | 3.3 | 2.9 | 3.48 |
Investing Cash Flow | -751.45 | -732.32 | -295.71 | -117.33 | -22.82 | -42.63 |
Short-Term Debt Issued | - | - | 68.43 | 1,571 | 1,188 | 1,449 |
Long-Term Debt Issued | - | 2,198 | 1,434 | - | - | - |
Total Debt Issued | 2,634 | 2,198 | 1,503 | 1,571 | 1,188 | 1,449 |
Short-Term Debt Repaid | - | -304.96 | -21.1 | -1,530 | -1,374 | -1,211 |
Long-Term Debt Repaid | - | -938.63 | -1,460 | -33.82 | -26.09 | - |
Total Debt Repaid | -1,571 | -1,244 | -1,481 | -1,564 | -1,400 | -1,211 |
Net Debt Issued (Repaid) | 1,062 | 954.32 | 21.62 | 7.14 | -212.25 | 237.61 |
Issuance of Common Stock | - | - | - | - | 401.86 | - |
Common Dividends Paid | -463.16 | -449.86 | -440.11 | -402.22 | -55.72 | -148.91 |
Other Financing Activities | -107.46 | -499.79 | 85.29 | -148.5 | -95.85 | 217.12 |
Financing Cash Flow | 491.85 | 4.67 | -333.2 | -543.58 | 38.04 | 305.81 |
Foreign Exchange Rate Adjustments | -0.27 | 2.21 | 0.72 | 5.87 | -1.18 | -1.08 |
Net Cash Flow | 612.97 | 88.4 | 171.31 | -349.29 | 195.33 | 145.27 |
Free Cash Flow | 568.3 | 509.86 | 614.01 | 200.43 | 153.81 | -133.19 |
Free Cash Flow Growth | -9.60% | -16.96% | 206.34% | 30.31% | - | - |
Free Cash Flow Margin | 7.50% | 6.30% | 7.44% | 2.67% | 2.18% | -2.27% |
Free Cash Flow Per Share | 1.04 | 0.94 | 1.15 | 0.38 | 0.31 | -0.28 |
Cash Income Tax Paid | 628.93 | 632.97 | 600.08 | 459.8 | 384.21 | 302.89 |
Levered Free Cash Flow | 335.86 | 791.34 | 340.46 | 171.77 | 45.79 | -165.18 |
Unlevered Free Cash Flow | 396.63 | 841.39 | 385.29 | 208.06 | 83.96 | -126.28 |
Change in Working Capital | -87.55 | -87.55 | -124.17 | -316.12 | -338.47 | -491.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.